| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Shoulder Joint | 49 | 2023 | 228 | 8.650 |
Why?
|
| Rotator Cuff Injuries | 33 | 2022 | 117 | 8.110 |
Why?
|
| Arthroscopy | 47 | 2022 | 267 | 8.010 |
Why?
|
| Rotator Cuff | 29 | 2022 | 108 | 6.270 |
Why?
|
| Joint Instability | 24 | 2023 | 145 | 5.810 |
Why?
|
| Tenodesis | 17 | 2022 | 53 | 5.070 |
Why?
|
| Tendon Injuries | 19 | 2022 | 81 | 4.300 |
Why?
|
| Humans | 174 | 2023 | 12240 | 4.080 |
Why?
|
| Anterior Cruciate Ligament Reconstruction | 16 | 2022 | 70 | 3.920 |
Why?
|
| Shoulder | 24 | 2022 | 92 | 3.800 |
Why?
|
| Anterior Cruciate Ligament Injuries | 15 | 2022 | 80 | 3.630 |
Why?
|
| Suture Anchors | 10 | 2023 | 39 | 3.100 |
Why?
|
| Shoulder Injuries | 13 | 2022 | 49 | 3.080 |
Why?
|
| Knee Joint | 27 | 2023 | 284 | 2.990 |
Why?
|
| Orthopedic Procedures | 17 | 2020 | 111 | 2.900 |
Why?
|
| Middle Aged | 73 | 2022 | 4043 | 2.830 |
Why?
|
| Treatment Outcome | 54 | 2023 | 1478 | 2.730 |
Why?
|
| Baseball | 8 | 2022 | 30 | 2.710 |
Why?
|
| Range of Motion, Articular | 40 | 2023 | 278 | 2.710 |
Why?
|
| Shoulder Dislocation | 9 | 2022 | 47 | 2.540 |
Why?
|
| Patient Reported Outcome Measures | 21 | 2023 | 165 | 2.530 |
Why?
|
| Adult | 67 | 2023 | 3557 | 2.470 |
Why?
|
| Male | 88 | 2022 | 6815 | 2.430 |
Why?
|
| Tendons | 13 | 2022 | 74 | 2.410 |
Why?
|
| Arthroplasty, Replacement, Shoulder | 12 | 2021 | 93 | 2.310 |
Why?
|
| Return to Sport | 6 | 2022 | 45 | 2.290 |
Why?
|
| Anterior Cruciate Ligament | 17 | 2022 | 76 | 2.280 |
Why?
|
| Cartilage, Articular | 10 | 2023 | 163 | 2.130 |
Why?
|
| Athletic Injuries | 12 | 2022 | 73 | 2.130 |
Why?
|
| Muscle, Skeletal | 13 | 2022 | 201 | 1.970 |
Why?
|
| Retrospective Studies | 37 | 2023 | 1467 | 1.860 |
Why?
|
| Female | 72 | 2022 | 6974 | 1.830 |
Why?
|
| Knee Injuries | 12 | 2023 | 69 | 1.750 |
Why?
|
| Biomechanical Phenomena | 29 | 2023 | 297 | 1.710 |
Why?
|
| Glenoid Cavity | 4 | 2022 | 16 | 1.700 |
Why?
|
| Bone Transplantation | 9 | 2023 | 82 | 1.680 |
Why?
|
| Cadaver | 21 | 2023 | 166 | 1.510 |
Why?
|
| Bone Screws | 6 | 2020 | 59 | 1.510 |
Why?
|
| Femur | 8 | 2018 | 190 | 1.460 |
Why?
|
| Tendinopathy | 4 | 2022 | 11 | 1.370 |
Why?
|
| Pain | 14 | 2023 | 193 | 1.270 |
Why?
|
| Collateral Ligament, Ulnar | 4 | 2023 | 10 | 1.250 |
Why?
|
| Aged | 36 | 2021 | 4000 | 1.250 |
Why?
|
| Minimal Clinically Important Difference | 7 | 2021 | 30 | 1.230 |
Why?
|
| Tibia | 6 | 2018 | 100 | 1.200 |
Why?
|
| Elbow Joint | 5 | 2023 | 52 | 1.190 |
Why?
|
| Postoperative Complications | 14 | 2021 | 385 | 1.160 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2019 | 281 | 1.120 |
Why?
|
| Tibial Meniscus Injuries | 4 | 2022 | 22 | 1.100 |
Why?
|
| Suture Techniques | 10 | 2023 | 65 | 1.090 |
Why?
|
| Arthroplasty, Subchondral | 4 | 2015 | 14 | 1.080 |
Why?
|
| Allografts | 7 | 2022 | 74 | 1.080 |
Why?
|
| Young Adult | 24 | 2023 | 863 | 1.030 |
Why?
|
| Shoulder Pain | 4 | 2018 | 24 | 0.990 |
Why?
|
| Orthopedics | 2 | 2018 | 32 | 0.950 |
Why?
|
| Bankart Lesions | 2 | 2023 | 9 | 0.940 |
Why?
|
| Wound Healing | 7 | 2017 | 55 | 0.930 |
Why?
|
| Osteoarthritis | 7 | 2020 | 168 | 0.930 |
Why?
|
| Arthroplasty | 6 | 2020 | 54 | 0.920 |
Why?
|
| Follow-Up Studies | 20 | 2021 | 726 | 0.900 |
Why?
|
| Prospective Studies | 14 | 2021 | 817 | 0.880 |
Why?
|
| Sports | 2 | 2022 | 20 | 0.860 |
Why?
|
| Humerus | 6 | 2021 | 48 | 0.860 |
Why?
|
| Arm | 7 | 2022 | 30 | 0.860 |
Why?
|
| Surgeons | 3 | 2021 | 43 | 0.840 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2016 | 68 | 0.840 |
Why?
|
| Recovery of Function | 11 | 2019 | 118 | 0.830 |
Why?
|
| Adolescent | 22 | 2023 | 989 | 0.810 |
Why?
|
| Shoulder Fractures | 2 | 2021 | 15 | 0.810 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2022 | 464 | 0.780 |
Why?
|
| Musculoskeletal Diseases | 1 | 2023 | 19 | 0.770 |
Why?
|
| Stress, Mechanical | 5 | 2019 | 86 | 0.750 |
Why?
|
| Menisci, Tibial | 6 | 2022 | 41 | 0.740 |
Why?
|
| Sports Medicine | 4 | 2022 | 17 | 0.740 |
Why?
|
| Open Fracture Reduction | 1 | 2021 | 5 | 0.700 |
Why?
|
| Quality Improvement | 2 | 2019 | 78 | 0.700 |
Why?
|
| Wounds and Injuries | 2 | 2019 | 21 | 0.670 |
Why?
|
| Ulnar Collateral Ligament Reconstruction | 2 | 2023 | 6 | 0.660 |
Why?
|
| Scapula | 7 | 2021 | 38 | 0.660 |
Why?
|
| Transplantation, Homologous | 9 | 2022 | 93 | 0.660 |
Why?
|
| Patient Satisfaction | 7 | 2021 | 118 | 0.650 |
Why?
|
| Bone Resorption | 3 | 2019 | 55 | 0.640 |
Why?
|
| Amputees | 1 | 2020 | 1 | 0.640 |
Why?
|
| Artificial Limbs | 1 | 2020 | 3 | 0.640 |
Why?
|
| Elbow | 3 | 2023 | 13 | 0.640 |
Why?
|
| Recurrence | 9 | 2021 | 126 | 0.630 |
Why?
|
| Surveys and Questionnaires | 9 | 2019 | 546 | 0.610 |
Why?
|
| Weight Lifting | 1 | 2019 | 5 | 0.600 |
Why?
|
| Demography | 1 | 2019 | 37 | 0.600 |
Why?
|
| Tissue Transplantation | 2 | 2016 | 9 | 0.570 |
Why?
|
| Bone Marrow Transplantation | 1 | 2018 | 10 | 0.570 |
Why?
|
| Osteoarthritis, Knee | 6 | 2023 | 169 | 0.570 |
Why?
|
| Internship and Residency | 1 | 2020 | 103 | 0.560 |
Why?
|
| Biological Products | 1 | 2018 | 16 | 0.560 |
Why?
|
| Bone Diseases | 1 | 2018 | 9 | 0.560 |
Why?
|
| Materials Testing | 2 | 2017 | 70 | 0.530 |
Why?
|
| Time Factors | 10 | 2020 | 695 | 0.530 |
Why?
|
| Osteochondritis Dissecans | 2 | 2015 | 11 | 0.510 |
Why?
|
| Workers' Compensation | 6 | 2021 | 28 | 0.500 |
Why?
|
| United States | 10 | 2021 | 989 | 0.500 |
Why?
|
| Activities of Daily Living | 6 | 2022 | 182 | 0.490 |
Why?
|
| Reoperation | 9 | 2020 | 366 | 0.490 |
Why?
|
| Orthopedic Surgeons | 1 | 2016 | 9 | 0.470 |
Why?
|
| Rupture | 9 | 2021 | 41 | 0.470 |
Why?
|
| Patient Readmission | 3 | 2021 | 48 | 0.460 |
Why?
|
| Football | 2 | 2017 | 8 | 0.450 |
Why?
|
| Femoral Neck Fractures | 1 | 2015 | 3 | 0.440 |
Why?
|
| Ligaments, Articular | 6 | 2023 | 50 | 0.430 |
Why?
|
| Acromion | 1 | 2014 | 4 | 0.420 |
Why?
|
| Patient Outcome Assessment | 1 | 2014 | 18 | 0.410 |
Why?
|
| Health Care Surveys | 1 | 2014 | 39 | 0.410 |
Why?
|
| Random Allocation | 4 | 2019 | 59 | 0.410 |
Why?
|
| Fracture Fixation, Internal | 3 | 2021 | 33 | 0.410 |
Why?
|
| Risk Factors | 9 | 2021 | 1049 | 0.410 |
Why?
|
| Postoperative Period | 8 | 2020 | 118 | 0.400 |
Why?
|
| Leishmaniasis, Visceral | 5 | 2015 | 5 | 0.390 |
Why?
|
| Hamstring Muscles | 3 | 2018 | 12 | 0.380 |
Why?
|
| Humeral Head | 3 | 2022 | 16 | 0.380 |
Why?
|
| Patellofemoral Joint | 2 | 2023 | 24 | 0.370 |
Why?
|
| Leg Injuries | 1 | 2012 | 7 | 0.370 |
Why?
|
| Electromyography | 4 | 2021 | 22 | 0.360 |
Why?
|
| Rotation | 7 | 2021 | 54 | 0.360 |
Why?
|
| ROC Curve | 3 | 2020 | 78 | 0.350 |
Why?
|
| Synovial Membrane | 3 | 2019 | 35 | 0.350 |
Why?
|
| Osseointegration | 1 | 2012 | 53 | 0.340 |
Why?
|
| Diagnostic Imaging | 4 | 2016 | 43 | 0.340 |
Why?
|
| Muscle Strength | 3 | 2017 | 46 | 0.340 |
Why?
|
| Odds Ratio | 3 | 2020 | 115 | 0.330 |
Why?
|
| Cohort Studies | 7 | 2020 | 827 | 0.330 |
Why?
|
| Cartilage Diseases | 2 | 2023 | 18 | 0.330 |
Why?
|
| Clavicle | 1 | 2010 | 5 | 0.320 |
Why?
|
| Acromioclavicular Joint | 1 | 2010 | 6 | 0.320 |
Why?
|
| Imaging, Three-Dimensional | 6 | 2021 | 81 | 0.320 |
Why?
|
| Animals | 13 | 2022 | 2092 | 0.320 |
Why?
|
| Aged, 80 and over | 12 | 2020 | 2152 | 0.320 |
Why?
|
| Work Capacity Evaluation | 1 | 2010 | 3 | 0.320 |
Why?
|
| Pain Measurement | 7 | 2020 | 211 | 0.320 |
Why?
|
| Patellar Ligament | 3 | 2014 | 21 | 0.320 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2010 | 73 | 0.310 |
Why?
|
| Collateral Ligaments | 2 | 2023 | 13 | 0.300 |
Why?
|
| Adrenal Cortex Hormones | 3 | 2021 | 55 | 0.300 |
Why?
|
| Tensile Strength | 3 | 2019 | 17 | 0.300 |
Why?
|
| Sex Factors | 6 | 2019 | 229 | 0.300 |
Why?
|
| Shoulder Prosthesis | 2 | 2020 | 15 | 0.300 |
Why?
|
| Sutures | 2 | 2019 | 13 | 0.290 |
Why?
|
| Leishmania donovani | 4 | 2013 | 4 | 0.290 |
Why?
|
| Athletes | 4 | 2022 | 30 | 0.280 |
Why?
|
| Osteotomy | 4 | 2017 | 66 | 0.270 |
Why?
|
| Treatment Failure | 5 | 2020 | 58 | 0.270 |
Why?
|
| Prosthesis Failure | 3 | 2010 | 229 | 0.260 |
Why?
|
| Pain, Postoperative | 4 | 2022 | 146 | 0.260 |
Why?
|
| Exercise Therapy | 2 | 2017 | 42 | 0.240 |
Why?
|
| Transplantation, Autologous | 6 | 2019 | 42 | 0.230 |
Why?
|
| Multivariate Analysis | 3 | 2020 | 141 | 0.230 |
Why?
|
| Tissue Banks | 2 | 2018 | 3 | 0.220 |
Why?
|
| Quality of Life | 3 | 2022 | 261 | 0.220 |
Why?
|
| Databases, Factual | 4 | 2019 | 156 | 0.220 |
Why?
|
| Incidence | 4 | 2019 | 338 | 0.220 |
Why?
|
| Hemiarthroplasty | 2 | 2016 | 18 | 0.220 |
Why?
|
| Algorithms | 3 | 2022 | 169 | 0.210 |
Why?
|
| Reproducibility of Results | 6 | 2021 | 324 | 0.200 |
Why?
|
| Case-Control Studies | 4 | 2016 | 256 | 0.190 |
Why?
|
| Arthroplasty, Replacement | 2 | 2016 | 49 | 0.190 |
Why?
|
| Pectoralis Muscles | 2 | 2013 | 10 | 0.190 |
Why?
|
| Patellar Dislocation | 1 | 2023 | 13 | 0.190 |
Why?
|
| Workload | 1 | 2022 | 12 | 0.190 |
Why?
|
| Severity of Illness Index | 5 | 2020 | 423 | 0.180 |
Why?
|
| Radiography | 4 | 2017 | 258 | 0.180 |
Why?
|
| Fractures, Bone | 1 | 2023 | 37 | 0.180 |
Why?
|
| Cost-Benefit Analysis | 2 | 2022 | 46 | 0.180 |
Why?
|
| Evidence-Based Medicine | 3 | 2014 | 78 | 0.180 |
Why?
|
| Ossification, Heterotopic | 1 | 2022 | 22 | 0.180 |
Why?
|
| Analgesics, Opioid | 2 | 2020 | 109 | 0.180 |
Why?
|
| Thigh | 2 | 2018 | 15 | 0.180 |
Why?
|
| Recruitment, Neurophysiological | 1 | 2021 | 1 | 0.180 |
Why?
|
| Neurological Rehabilitation | 1 | 2021 | 2 | 0.180 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2022 | 46 | 0.180 |
Why?
|
| Quadriplegia | 1 | 2021 | 2 | 0.180 |
Why?
|
| Bone Plates | 1 | 2021 | 19 | 0.180 |
Why?
|
| Bone Marrow | 1 | 2022 | 35 | 0.170 |
Why?
|
| Hand | 1 | 2021 | 24 | 0.170 |
Why?
|
| Spinal Cord Injuries | 1 | 2021 | 17 | 0.170 |
Why?
|
| Wearable Electronic Devices | 1 | 2021 | 21 | 0.170 |
Why?
|
| Joint Prosthesis | 2 | 2013 | 43 | 0.170 |
Why?
|
| Depression | 2 | 2020 | 229 | 0.170 |
Why?
|
| Platelet-Rich Plasma | 1 | 2021 | 20 | 0.170 |
Why?
|
| Equipment Design | 2 | 2020 | 76 | 0.170 |
Why?
|
| Prosthesis Design | 2 | 2019 | 195 | 0.170 |
Why?
|
| Bone-Patellar Tendon-Bone Grafting | 2 | 2012 | 13 | 0.170 |
Why?
|
| Length of Stay | 2 | 2021 | 126 | 0.160 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 400 | 0.160 |
Why?
|
| Area Under Curve | 1 | 2020 | 39 | 0.160 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 18 | 0.160 |
Why?
|
| Ankle | 1 | 2020 | 14 | 0.160 |
Why?
|
| Perioperative Period | 1 | 2020 | 6 | 0.160 |
Why?
|
| Logistic Models | 1 | 2020 | 196 | 0.150 |
Why?
|
| Benzophenones | 1 | 2019 | 4 | 0.150 |
Why?
|
| Information Dissemination | 1 | 2020 | 8 | 0.150 |
Why?
|
| Video Recording | 1 | 2020 | 16 | 0.150 |
Why?
|
| Meniscus | 1 | 2020 | 7 | 0.150 |
Why?
|
| Ketones | 1 | 2019 | 6 | 0.150 |
Why?
|
| Mental Health | 1 | 2020 | 47 | 0.150 |
Why?
|
| Polymers | 1 | 2019 | 16 | 0.150 |
Why?
|
| Polyethylene Glycols | 1 | 2019 | 10 | 0.150 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 23 | 0.150 |
Why?
|
| Bacteria | 1 | 2019 | 34 | 0.150 |
Why?
|
| Patient Education as Topic | 1 | 2020 | 64 | 0.150 |
Why?
|
| Research Subjects | 1 | 2019 | 6 | 0.150 |
Why?
|
| Bacterial Infections | 1 | 2019 | 26 | 0.150 |
Why?
|
| Fractures, Stress | 1 | 2019 | 11 | 0.150 |
Why?
|
| Social Media | 1 | 2020 | 32 | 0.150 |
Why?
|
| Time | 1 | 2019 | 10 | 0.150 |
Why?
|
| Skin | 1 | 2019 | 73 | 0.150 |
Why?
|
| Corneal Opacity | 1 | 1999 | 1 | 0.150 |
Why?
|
| Osteosarcoma, Juxtacortical | 1 | 1999 | 1 | 0.150 |
Why?
|
| Femoral Neoplasms | 1 | 1999 | 2 | 0.150 |
Why?
|
| Motivation | 1 | 2019 | 47 | 0.150 |
Why?
|
| Keratoplasty, Penetrating | 1 | 1999 | 9 | 0.140 |
Why?
|
| Rabbits | 3 | 2015 | 110 | 0.140 |
Why?
|
| Bone Density | 1 | 2019 | 110 | 0.140 |
Why?
|
| Tissue and Organ Harvesting | 2 | 2012 | 8 | 0.140 |
Why?
|
| Bone Marrow Cells | 1 | 2018 | 40 | 0.140 |
Why?
|
| Pudendal Nerve | 1 | 2018 | 3 | 0.140 |
Why?
|
| Surgical Wound Infection | 1 | 2018 | 38 | 0.140 |
Why?
|
| Pneumonia | 1 | 2018 | 33 | 0.130 |
Why?
|
| Models, Animal | 3 | 2015 | 74 | 0.130 |
Why?
|
| Pulmonary Embolism | 1 | 2018 | 32 | 0.130 |
Why?
|
| Humeral Fractures | 1 | 2017 | 7 | 0.130 |
Why?
|
| Fever | 1 | 2017 | 18 | 0.130 |
Why?
|
| Osteoporosis | 1 | 2018 | 51 | 0.130 |
Why?
|
| Return to Work | 2 | 2015 | 18 | 0.130 |
Why?
|
| Coracoid Process | 1 | 2017 | 3 | 0.130 |
Why?
|
| Equipment Failure | 1 | 2017 | 9 | 0.130 |
Why?
|
| Hospital Charges | 1 | 2017 | 9 | 0.130 |
Why?
|
| Injections, Intra-Articular | 3 | 2023 | 31 | 0.130 |
Why?
|
| Reference Values | 3 | 2019 | 103 | 0.130 |
Why?
|
| Bone and Bones | 1 | 2018 | 83 | 0.130 |
Why?
|
| Patient Preference | 1 | 2017 | 20 | 0.130 |
Why?
|
| Biomarkers | 2 | 2015 | 294 | 0.120 |
Why?
|
| Muscular Atrophy | 1 | 2016 | 7 | 0.120 |
Why?
|
| Biocompatible Materials | 1 | 2016 | 42 | 0.120 |
Why?
|
| Lipopolysaccharide Receptors | 2 | 2013 | 5 | 0.120 |
Why?
|
| Movement | 1 | 2016 | 58 | 0.120 |
Why?
|
| Synovial Fluid | 2 | 2015 | 53 | 0.120 |
Why?
|
| Liver Abscess, Amebic | 1 | 1995 | 1 | 0.110 |
Why?
|
| Age Factors | 5 | 2020 | 350 | 0.110 |
Why?
|
| Capsaicin | 1 | 2015 | 5 | 0.110 |
Why?
|
| Developing Countries | 1 | 1995 | 7 | 0.110 |
Why?
|
| Chondrogenesis | 1 | 2015 | 23 | 0.110 |
Why?
|
| Knee Prosthesis | 1 | 2016 | 92 | 0.110 |
Why?
|
| Hypertriglyceridemia | 1 | 2015 | 15 | 0.110 |
Why?
|
| Computer Simulation | 3 | 2022 | 90 | 0.110 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 21 | 0.110 |
Why?
|
| Chemokines | 1 | 2015 | 5 | 0.110 |
Why?
|
| Time-to-Treatment | 1 | 2015 | 14 | 0.110 |
Why?
|
| Clinical Trials as Topic | 2 | 2013 | 100 | 0.100 |
Why?
|
| Debridement | 2 | 2011 | 31 | 0.100 |
Why?
|
| CD58 Antigens | 1 | 2013 | 1 | 0.100 |
Why?
|
| Patient Selection | 2 | 2012 | 111 | 0.100 |
Why?
|
| Trypanocidal Agents | 1 | 2012 | 1 | 0.090 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2012 | 1 | 0.090 |
Why?
|
| Phosphorylcholine | 1 | 2012 | 3 | 0.090 |
Why?
|
| Spleen | 1 | 2012 | 15 | 0.090 |
Why?
|
| Skin Diseases | 1 | 2012 | 9 | 0.090 |
Why?
|
| Tendon Transfer | 1 | 2012 | 6 | 0.090 |
Why?
|
| Muscle Strength Dynamometer | 1 | 2012 | 6 | 0.090 |
Why?
|
| Child | 4 | 2016 | 614 | 0.090 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2012 | 13 | 0.090 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2012 | 17 | 0.090 |
Why?
|
| Sterilization | 1 | 2012 | 5 | 0.090 |
Why?
|
| Gamma Rays | 1 | 2012 | 8 | 0.090 |
Why?
|
| Tissue Preservation | 1 | 2012 | 1 | 0.090 |
Why?
|
| Ankle Joint | 1 | 2012 | 21 | 0.090 |
Why?
|
| Graft Survival | 1 | 2012 | 44 | 0.090 |
Why?
|
| Shoulder Impingement Syndrome | 1 | 2011 | 3 | 0.080 |
Why?
|
| Cartilage | 2 | 2016 | 41 | 0.080 |
Why?
|
| Functional Laterality | 1 | 2010 | 21 | 0.080 |
Why?
|
| Reference Standards | 1 | 2010 | 7 | 0.080 |
Why?
|
| Pressure | 4 | 2015 | 24 | 0.080 |
Why?
|
| Decompression, Surgical | 1 | 2011 | 60 | 0.080 |
Why?
|
| Occupations | 1 | 2010 | 8 | 0.080 |
Why?
|
| Ilium | 1 | 2010 | 19 | 0.080 |
Why?
|
| Weight-Bearing | 2 | 2014 | 72 | 0.070 |
Why?
|
| Endemic Diseases | 2 | 2006 | 5 | 0.070 |
Why?
|
| Freezing | 1 | 2009 | 6 | 0.070 |
Why?
|
| Elasticity | 1 | 2009 | 19 | 0.070 |
Why?
|
| Hand Injuries | 1 | 2009 | 7 | 0.070 |
Why?
|
| Arthroplasty, Replacement, Knee | 2 | 2009 | 264 | 0.070 |
Why?
|
| Physical Therapy Modalities | 1 | 2009 | 31 | 0.070 |
Why?
|
| Swine | 2 | 2009 | 43 | 0.070 |
Why?
|
| Joint Capsule | 1 | 2007 | 21 | 0.070 |
Why?
|
| Postoperative Care | 2 | 2020 | 43 | 0.060 |
Why?
|
| Disability Evaluation | 1 | 2007 | 105 | 0.060 |
Why?
|
| Wuchereria bancrofti | 1 | 2006 | 1 | 0.060 |
Why?
|
| Elephantiasis, Filarial | 1 | 2006 | 2 | 0.060 |
Why?
|
| Rural Population | 1 | 2006 | 8 | 0.060 |
Why?
|
| India | 3 | 2006 | 8 | 0.060 |
Why?
|
| Traction | 1 | 2005 | 16 | 0.060 |
Why?
|
| Venous Thrombosis | 1 | 2005 | 21 | 0.060 |
Why?
|
| Health Status Indicators | 3 | 2010 | 38 | 0.050 |
Why?
|
| Ligaments | 1 | 2023 | 6 | 0.050 |
Why?
|
| Knee | 1 | 2023 | 16 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2014 | 128 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2023 | 166 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2006 | 320 | 0.050 |
Why?
|
| Iatrogenic Disease | 1 | 2022 | 13 | 0.050 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2022 | 15 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2014 | 295 | 0.050 |
Why?
|
| Physical Examination | 2 | 2014 | 37 | 0.050 |
Why?
|
| Documentation | 1 | 2022 | 13 | 0.040 |
Why?
|
| Age Distribution | 2 | 2016 | 25 | 0.040 |
Why?
|
| Sex Distribution | 2 | 2016 | 34 | 0.040 |
Why?
|
| Upper Extremity | 1 | 2021 | 10 | 0.040 |
Why?
|
| Network Meta-Analysis | 1 | 2021 | 6 | 0.040 |
Why?
|
| Prognosis | 2 | 2015 | 363 | 0.040 |
Why?
|
| Machine Learning | 1 | 2021 | 31 | 0.040 |
Why?
|
| Hyaluronic Acid | 1 | 2021 | 23 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2021 | 113 | 0.040 |
Why?
|
| Ultrasonography | 2 | 2009 | 152 | 0.040 |
Why?
|
| Medicaid | 1 | 2021 | 23 | 0.040 |
Why?
|
| Information Systems | 1 | 2021 | 4 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2021 | 77 | 0.040 |
Why?
|
| Medicare | 1 | 2021 | 59 | 0.040 |
Why?
|
| Dermis | 1 | 2020 | 4 | 0.040 |
Why?
|
| Psychodidae | 1 | 2000 | 1 | 0.040 |
Why?
|
| DNA Probes | 1 | 2000 | 3 | 0.040 |
Why?
|
| Musculoskeletal Pain | 1 | 2020 | 13 | 0.040 |
Why?
|
| Preoperative Care | 1 | 2020 | 42 | 0.040 |
Why?
|
| Visual Analog Scale | 1 | 2020 | 18 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2020 | 34 | 0.040 |
Why?
|
| Survivorship | 1 | 2020 | 4 | 0.040 |
Why?
|
| Quality Assurance, Health Care | 1 | 2020 | 18 | 0.040 |
Why?
|
| Prevalence | 2 | 2014 | 175 | 0.040 |
Why?
|
| Quality Control | 1 | 2020 | 12 | 0.040 |
Why?
|
| Morphine | 1 | 2020 | 40 | 0.040 |
Why?
|
| Colony Count, Microbial | 1 | 2019 | 9 | 0.040 |
Why?
|
| Patient Participation | 1 | 2019 | 25 | 0.040 |
Why?
|
| Pupil | 1 | 1999 | 3 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2019 | 10 | 0.040 |
Why?
|
| Visual Acuity | 1 | 1999 | 22 | 0.040 |
Why?
|
| Software | 1 | 2019 | 26 | 0.040 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2019 | 38 | 0.040 |
Why?
|
| Tissue Donors | 1 | 1999 | 42 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 1999 | 151 | 0.030 |
Why?
|
| Sciatic Nerve | 1 | 2018 | 15 | 0.030 |
Why?
|
| Dissection | 1 | 2018 | 16 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 207 | 0.030 |
Why?
|
| Basketball | 1 | 2017 | 3 | 0.030 |
Why?
|
| Hockey | 1 | 2017 | 2 | 0.030 |
Why?
|
| Tarsal Bones | 1 | 2016 | 3 | 0.030 |
Why?
|
| Transplants | 1 | 2016 | 5 | 0.030 |
Why?
|
| Chondrocytes | 1 | 2016 | 58 | 0.030 |
Why?
|
| Quadriceps Muscle | 1 | 2016 | 16 | 0.030 |
Why?
|
| Epidemiologic Methods | 1 | 2016 | 6 | 0.030 |
Why?
|
| Arthrography | 1 | 2015 | 12 | 0.030 |
Why?
|
| Collagen Type III | 1 | 2015 | 7 | 0.030 |
Why?
|
| Parasite Load | 1 | 2015 | 1 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2015 | 11 | 0.030 |
Why?
|
| Tissue Scaffolds | 1 | 2015 | 15 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 46 | 0.030 |
Why?
|
| Smoking | 1 | 2016 | 84 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2015 | 59 | 0.030 |
Why?
|
| Chemokine CCL19 | 1 | 2015 | 2 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2015 | 67 | 0.030 |
Why?
|
| Fibrocartilage | 1 | 2015 | 2 | 0.030 |
Why?
|
| Occupational Injuries | 1 | 2015 | 4 | 0.030 |
Why?
|
| Liver | 1 | 1995 | 57 | 0.030 |
Why?
|
| Arthralgia | 1 | 2015 | 56 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 37 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2015 | 157 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2014 | 12 | 0.030 |
Why?
|
| Gait | 1 | 2016 | 195 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 125 | 0.030 |
Why?
|
| Joint Diseases | 1 | 2014 | 44 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2014 | 30 | 0.030 |
Why?
|
| Amphotericin B | 1 | 2013 | 4 | 0.020 |
Why?
|
| Antiprotozoal Agents | 1 | 2013 | 7 | 0.020 |
Why?
|
| Injury Severity Score | 1 | 2013 | 8 | 0.020 |
Why?
|
| Gene Expression | 1 | 2013 | 97 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 116 | 0.020 |
Why?
|
| Acute Disease | 1 | 2013 | 90 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2012 | 47 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2012 | 55 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2005 | 252 | 0.020 |
Why?
|
| Lipopeptides | 1 | 2012 | 6 | 0.020 |
Why?
|
| Contraindications | 1 | 2012 | 18 | 0.020 |
Why?
|
| Observer Variation | 1 | 2012 | 47 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2012 | 41 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2012 | 186 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2012 | 221 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2012 | 132 | 0.020 |
Why?
|
| Tenotomy | 1 | 2010 | 6 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 72 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 125 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2010 | 105 | 0.020 |
Why?
|
| Mice | 1 | 2012 | 760 | 0.020 |
Why?
|
| Polyethylene | 1 | 2010 | 52 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2009 | 42 | 0.020 |
Why?
|
| Surface Properties | 1 | 2009 | 66 | 0.020 |
Why?
|
| Sus scrofa | 1 | 2009 | 4 | 0.020 |
Why?
|
| Culex | 1 | 2006 | 1 | 0.010 |
Why?
|
| Insect Vectors | 1 | 2006 | 1 | 0.010 |
Why?
|
| Microfilariae | 1 | 2006 | 2 | 0.010 |
Why?
|
| Antigens, Protozoan | 1 | 2005 | 1 | 0.010 |
Why?
|
| Agglutination Tests | 1 | 2005 | 2 | 0.010 |
Why?
|
| Early Diagnosis | 1 | 2005 | 27 | 0.010 |
Why?
|
| Axillary Vein | 1 | 2005 | 1 | 0.010 |
Why?
|
| Ultrasonography, Doppler | 1 | 2005 | 4 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2006 | 214 | 0.010 |
Why?
|
| Selection Bias | 1 | 2005 | 4 | 0.010 |
Why?
|
| Thrombolytic Therapy | 1 | 2005 | 21 | 0.010 |
Why?
|
| Infant | 1 | 2006 | 277 | 0.010 |
Why?
|
| Disease Progression | 1 | 2005 | 290 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2006 | 312 | 0.010 |
Why?
|
| Digoxigenin | 1 | 2000 | 1 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 1977 | 40 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 1977 | 6 | 0.000 |
Why?
|
| Health Surveys | 1 | 1977 | 38 | 0.000 |
Why?
|
| Body Weight | 1 | 1977 | 72 | 0.000 |
Why?
|
| Blood Glucose | 1 | 1977 | 53 | 0.000 |
Why?
|
| Attitude to Health | 1 | 1977 | 55 | 0.000 |
Why?
|
| Mass Screening | 1 | 1977 | 86 | 0.000 |
Why?
|